Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Designs for group sequential tests.

T R Fleming, D P Harrington, P C O'Brien

    Controlled Clinical Trials
    |December 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a novel group sequential design for clinical trials, allowing early termination with extreme results while preserving statistical power. The flexible design also accommodates adjustments for slow patient accrual.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Multiple imputation in a large-scale complex survey: a practical guide.

    Statistical methods in medical research·2009
    Same author

    Molecular cytogenetic characterization of the EBV-producing cell line B95-8 (Saguinus oedipus, Platyrrhini) by chromosome sorting and painting.

    Chromosome research : an international journal on the molecular, supramolecular and evolutionary aspects of chromosome biology·2002
    Same author

    FLAIR histogram segmentation for measurement of leukoaraiosis volume.

    Journal of magnetic resonance imaging : JMRI·2001
    Same author

    Feasibility of an affected sibling pair study in ischemic stroke: results of a 2-center family history registry.

    Stroke·2001
    Same author

    The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial.

    Diabetologia·2001
    Same author

    Increased weakness after pancreas and kidney transplantation.

    Transplantation·2001
    Same journal

    On the generation and ownership of alpha in medical studies.

    Controlled clinical trials·2004
    Same journal

    An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia.

    Controlled clinical trials·2004
    Same journal

    Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture.

    Controlled clinical trials·2004
    Same journal

    Statistical comparison of random allocation methods in cancer clinical trials.

    Controlled clinical trials·2004
    Same journal

    Analyzing bronchodilation with emphasis on disease type, age and sex.

    Controlled clinical trials·2004
    Same journal

    Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in acute myocardial infarction.

    Controlled clinical trials·2004
    See all related articles

    Area of Science:

    • Clinical Trials
    • Biostatistics
    • Medical Ethics

    Background:

    • Group sequential procedures are crucial for ethical clinical trial interim analyses.
    • Existing methods balance early stopping with maintaining statistical power.

    Purpose of the Study:

    • To propose an alternative group sequential procedure for clinical trials.
    • To offer enhanced opportunities for early trial termination based on extreme interim results.
    • To maintain the statistical power of traditional final analysis methods.

    Main Methods:

    • Development of a new group sequential design for clinical trials.
    • Incorporation of flexibility for adjusting the maximum number of analyses.
    • Ensuring the design does not allow adjustments based on observed interim outcomes.

    Related Experiment Videos

    Main Results:

    • The proposed procedure allows for early termination with extreme initial findings.
    • It substantially preserves the statistical power of a standard final analysis.
    • The design is adaptable for logistical reasons like slow patient accrual.

    Conclusions:

    • The novel group sequential design provides an ethical and efficient alternative for clinical trials.
    • It balances the need for interim analyses with maintaining study power and flexibility.
    • This approach supports robust clinical trial conduct and timely decision-making.